1. Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil. Issue 12 (9th June 2021) Authors: Trivedi, Ashit; Oberoi, Rajneet K.; Mackowski, Mia; Jafarinasabian, Pegah; Zhang, Hanze; Flach, Stephen; Hutton, Shauna; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 12(2021) Page Start: 1442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives. Issue 2 (March 2013) Authors: Trivedi, Ashit; Lee, Richard E; Meibohm, Bernd Journal: Expert review of clinical pharmacology Issue: Volume 6:Issue 2(2013) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects. Issue 1 (16th July 2021) Authors: Trivedi, Ashit; Sohn, Winnie; Jafarinasabian, Pegah; Zhang, Hanze; Terminello, Bianca; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects. Issue 3 (11th October 2021) Authors: Trivedi, Ashit; Sohn, Winnie; Hsu, Cheng‐Pang; Jafarinasabian, Pegah; Zhang, Hanze; Hutton, Shauna; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 3(2022) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations. Issue 1 (16th July 2021) Authors: Trivedi, Ashit; Hsu, Cheng‐Pang; Jafarinasabian, Pegah; Terminello, Bianca; Zhang, Hanze; Flach, Stephen; Israel, Samuel; Brooks, Ashley; Xue, Hongqi; Darpo, Borje; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Other Names: Magavern Emma guestEditor.; Piasecki Jan guestEditor.; Cremers Serge guestEditor.; Cohen Adam guestEditor. Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 1(2022) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model. Issue 6 (20th August 2021) Authors: Trivedi, Ashit; Sohn, Winnie; Kulkarni, Priyanka; Jafarinasabian, Pegah; Zhang, Hanze; Spring, Marintan; Flach, Stephen; Abbasi, Siddique; Wahlstrom, Jan; Lee, Edward; Dutta, Sandeep Journal: Clinical and translational science Issue: Volume 14:Issue 6(2021) Page Start: 2510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Phase 1, Open‐Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects. Issue 7 (5th March 2022) Authors: Trivedi, Ashit; Mather, Omar; Vega, Silvia; Hutton, Shauna; Hellawell, Jennifer; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 7(2022) Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator. (18th June 2021) Authors: Trivedi, Ashit; Oberoi, Rajneet K.; Mackowski, Mia; Jafarinasabian, Pegah; Zhang, Hanze; Flach, Stephen; Simiens, Mary Ann; Terminello, Bianca; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Biopharmaceutics & drug disposition Issue: Volume 42:Number 7(2021) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug‐Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open‐Label Studies in Healthy Subjects. Issue 2 (19th June 2021) Authors: Trivedi, Ashit; Malik, Fady I.; Jafarinasabian, Pegah; Zhang, Hanze; Flach, Stephen; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 2(2022) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Population Pharmacokinetic Properties of Omecamtiv Mecarbil in Healthy Subjects and Patients With Heart Failure With Reduced Ejection Fraction. Issue 4 (April 2022) Authors: Chen, Po-Wei; Trivedi, Ashit; Lee, Edward; Dutta, Sandeep; Ahamadi, Malidi Journal: Journal of cardiovascular pharmacology Issue: Volume 79:Issue 4(2022) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗